Please regularly visit the following websites and directly search for funding opportunities and deadlines in your research field.
New Opportunities
Advancing HIV service delivery through pharmacies and pharmacists: The National Institutes of Health has released two new Notice of Funding Opportunities (NOFO) soliciting "research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes the advancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness." Both the R21 and R01 mechanisms will be used for these programs. More information is available within each NOFO. Applications are due August 13, 2024.
Federal Agencies
NIH Grants & Funding: A searchable database maintained by the NIH Office of Extramural Research on currently available biomedical research funding and training opportunities related to human health and diseases. Notice of Funding Opportunity of particular interest for pharmacy include:
- The Medical Scientist Training Program (MSTP) T32: "The goal of the Medical Scientist Training Program (MSTP) is to develop a diverse pool of well-trained clinician-scientist leaders available to address the nation’s biomedical research needs. Specifically, this funding announcement provides support to eligible, domestic organizations to develop and implement effective, evidence-informed approaches to dual-degree training and mentoring that will keep pace with the rapid evolution of the biomedical research enterprise and lead to the completion of both a clinical degree (for example, M.D., D.O., D.V.M., D.D.S., Pharm.D., etc.) and a research doctorate degree (Ph.D.)." Upcoming due dates: May 25, 2024, September 25, 2024, January 25, 2025
- Advancing HIV service delivery through pharmacies and pharmacists: "The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes the advancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness." Application due date August 13, 2024.
- R01 (Clinical Trial Optional): Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.
- R21 (Clinical Trial Optional): Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism.
NSF Funding: The Foundation supports basic research and education in most fields, including biological, chemical, environmental, social, behavioral and economical sciences, collaborative research between universities and industry, and graduate and postdoctoral fellowships.
CDC Funding: Supports research to keep Americans safe and healthy both domestically and abroad.
USDA NIFA Grants: Supports research and fellowships on nutrition and health, education, environment, biotechnology and genomics, economics and community development.
AHRQ Funding & Grants: Supports research to improve the quality, safety, efficiency, and effectiveness of healthcare for all Americans.
DOD Grants: The Department of Defense (DOD) Office of Congressionally Directed Medical Research Programs (CDMRP) supports biomedical research across the development pipeline from basic to clinical through annual funding opportunities.
Additional Organizations, Associations and Foundations
Proposal Central Provides access to funding opportunities funders including the Alzheimer’s Association, American Association for Cancer Research, Burroughs Wellcome Fund, and many others
American Brain Tumor Association
American Respiratory Care Foundation
International Rett Syndrome Foundation
National Pharmaceutical Council
Patient-Centered Outcomes Research Institute